Global Durvalumab Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
SKU ID : GIR-18228504 | Publishing Date : 12-May-2021 | No. of pages : 106
Detailed TOC of Global Durvalumab Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Market Overview1.1 Durvalumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Durvalumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 2.4mL Injection
1.2.3 10mL Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Durvalumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Locally Advanced Urothelial Carcinoma
1.3.3 Metastatic Urothelial Carcinoma
1.3.4 Other
1.4 Global Durvalumab Market Size & Forecast
1.4.1 Global Durvalumab Sales in Value (2016-2026))
1.4.2 Global Durvalumab Sales in Volume (2016-2026)
1.4.3 Global Durvalumab Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Durvalumab Production Capacity Analysis
1.5.1 Global Durvalumab Total Production Capacity (2016-2026)
1.5.2 Global Durvalumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Durvalumab Market Drivers
1.6.2 Durvalumab Market Restraints
1.6.3 Durvalumab Trends Analysis
2 Manufacturers Profiles
2.1 Medimmune (AstraZeneca)
2.1.1 Medimmune (AstraZeneca) Details
2.1.2 Medimmune (AstraZeneca) Major Business
2.1.3 Medimmune (AstraZeneca) Durvalumab Product and Services
2.1.4 Medimmune (AstraZeneca) Durvalumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Durvalumab Sales by Manufacturer
3.1 Global Durvalumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Durvalumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Durvalumab
3.4 Market Concentration Rate
3.4.1 Top 3 Durvalumab Manufacturer Market Share
3.4.2 Top 6 Durvalumab Manufacturer Market Share
3.5 Global Durvalumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Durvalumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Durvalumab Market Size by Region
4.1.1 Global Durvalumab Sales in Volume by Region (2016-2026)
4.1.2 Global Durvalumab Revenue by Region (2016-2026)
4.2 North America Durvalumab Revenue (2016-2026)
4.3 Europe Durvalumab Revenue (2016-2026)
4.4 Asia-Pacific Durvalumab Revenue (2016-2026)
4.5 South America Durvalumab Revenue (2016-2026)
4.6 Middle East and Africa Durvalumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Durvalumab Sales in Volume by Type (2016-2026)
5.2 Global Durvalumab Revenue by Type (2016-2026)
5.3 Global Durvalumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Durvalumab Sales in Volume by Application (2016-2026)
6.2 Global Durvalumab Revenue by Application (2016-2026)
6.3 Global Durvalumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Durvalumab Sales by Type (2016-2026)
7.2 North America Durvalumab Sales by Application (2016-2026)
7.3 North America Durvalumab Market Size by Country
7.3.1 North America Durvalumab Sales in Volume by Country (2016-2026)
7.3.2 North America Durvalumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Durvalumab Sales by Type (2016-2026)
8.2 Europe Durvalumab Sales by Application (2016-2026)
8.3 Europe Durvalumab Market Size by Country
8.3.1 Europe Durvalumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Durvalumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Durvalumab Sales by Type (2016-2026)
9.2 Asia-Pacific Durvalumab Sales by Application (2016-2026)
9.3 Asia-Pacific Durvalumab Market Size by Region
9.3.1 Asia-Pacific Durvalumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Durvalumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Durvalumab Sales by Type (2016-2026)
10.2 South America Durvalumab Sales by Application (2016-2026)
10.3 South America Durvalumab Market Size by Country
10.3.1 South America Durvalumab Sales in Volume by Country (2016-2026)
10.3.2 South America Durvalumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Durvalumab Sales by Type (2016-2026)
11.2 Middle East & Africa Durvalumab Sales by Application (2016-2026)
11.3 Middle East & Africa Durvalumab Market Size by Country
11.3.1 Middle East & Africa Durvalumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Durvalumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Durvalumab Typical Distributors
12.3 Durvalumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Durvalumab Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
List of TablesTable 1. Global Durvalumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Durvalumab Revenue by Application, (USD Million), 2021-2026
Table 3. Medimmune (AstraZeneca) Basic Information, Manufacturing Base and Competitors
Table 4. Medimmune (AstraZeneca) Major Business
Table 5. Medimmune (AstraZeneca) Durvalumab Product and Services
Table 6. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Durvalumab Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 8. Global Durvalumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Durvalumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Durvalumab Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 11. Head Office and Durvalumab Production Site of Key Manufacturer
Table 12. Durvalumab New Entrant and Capacity Expansion Plans
Table 13. Durvalumab Mergers & Acquisitions in the Past Five Years
Table 14. Global Durvalumab Sales by Region (2016-2021e) & (K Pcs)
Table 15. Global Durvalumab Sales by Region (2021-2026) & (K Pcs)
Table 16. Global Durvalumab Revenue by Region (2016-2021e) & (USD Million)
Table 17. Global Durvalumab Revenue by Region (2021-2026) & (USD Million)
Table 18. Global Durvalumab Sales by Type (2016-2021e) & (K Pcs)
Table 19. Global Durvalumab Sales by Type (2021-2026) & (K Pcs)
Table 20. Global Durvalumab Revenue by Type (2016-2021e) & (USD Million)
Table 21. Global Durvalumab Revenue by Type (2021-2026) & (USD Million)
Table 22. Global Durvalumab Price by Type (2016-2021e) & (USD/Pcs)
Table 23. Global Durvalumab Price by Type (2021-2026) & (USD/Pcs)
Table 24. Global Durvalumab Sales by Application (2016-2021e) & (K Pcs)
Table 25. Global Durvalumab Sales by Application (2021-2026) & (K Pcs)
Table 26. Global Durvalumab Revenue by Application (2016-2021e) & (USD Million)
Table 27. Global Durvalumab Revenue by Application (2021-2026) & (USD Million)
Table 28. Global Durvalumab Price by Application (2016-2021e) & (USD/Pcs)
Table 29. Global Durvalumab Price by Application (2021-2026) & (USD/Pcs)
Table 30. North America Durvalumab Sales by Country (2016-2021e) & (K Pcs)
Table 31. North America Durvalumab Sales by Country (2021-2026) & (K Pcs)
Table 32. North America Durvalumab Revenue by Country (2016-2021e) & (USD Million)
Table 33. North America Durvalumab Revenue by Country (2021-2026) & (USD Million)
Table 34. North America Durvalumab Sales by Type (2016-2021e) & (K Pcs)
Table 35. North America Durvalumab Sales by Type (2021-2026) & (K Pcs)
Table 36. North America Durvalumab Sales by Application (2016-2021e) & (K Pcs)
Table 37. North America Durvalumab Sales by Application (2021-2026) & (K Pcs)
Table 38. Europe Durvalumab Sales by Country (2016-2021e) & (K Pcs)
Table 39. Europe Durvalumab Sales by Country (2021-2026) & (K Pcs)
Table 40. Europe Durvalumab Revenue by Country (2016-2021e) & (USD Million)
Table 41. Europe Durvalumab Revenue by Country (2021-2026) & (USD Million)
Table 42. Europe Durvalumab Sales by Type (2016-2021e) & (K Pcs)
Table 43. Europe Durvalumab Sales by Type (2021-2026) & (K Pcs)
Table 44. Europe Durvalumab Sales by Application (2016-2021e) & (K Pcs)
Table 45. Europe Durvalumab Sales by Application (2021-2026) & (K Pcs)
Table 46. Asia-Pacific Durvalumab Sales by Region (2016-2021e) & (K Pcs)
Table 47. Asia-Pacific Durvalumab Sales by Region (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Durvalumab Revenue by Region (2016-2021e) & (USD Million)
Table 49. Asia-Pacific Durvalumab Revenue by Region (2021-2026) & (USD Million)
Table 50. Asia-Pacific Durvalumab Sales by Type (2016-2021e) & (K Pcs)
Table 51. Asia-Pacific Durvalumab Sales by Type (2021-2026) & (K Pcs)
Table 52. Asia-Pacific Durvalumab Sales by Application (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Durvalumab Sales by Application (2021-2026) & (K Pcs)
Table 54. South America Durvalumab Sales by Country (2016-2021e) & (K Pcs)
Table 55. South America Durvalumab Sales by Country (2021-2026) & (K Pcs)
Table 56. South America Durvalumab Revenue by Country (2016-2021e) & (USD Million)
Table 57. South America Durvalumab Revenue by Country (2021-2026) & (USD Million)
Table 58. South America Durvalumab Sales by Type (2016-2021e) & (K Pcs)
Table 59. South America Durvalumab Sales by Type (2021-2026) & (K Pcs)
Table 60. South America Durvalumab Sales by Application (2016-2021e) & (K Pcs)
Table 61. South America Durvalumab Sales by Application (2021-2026) & (K Pcs)
Table 62. Middle East & Africa Durvalumab Sales by Country (2016-2021e) & (K Pcs)
Table 63. Middle East & Africa Durvalumab Sales by Country (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Durvalumab Revenue by Country (2016-2021e) & (USD Million)
Table 65. Middle East & Africa Durvalumab Revenue by Country (2021-2026) & (USD Million)
Table 66. Middle East & Africa Durvalumab Sales by Type (2016-2021e) & (K Pcs)
Table 67. Middle East & Africa Durvalumab Sales by Type (2021-2026) & (K Pcs)
Table 68. Middle East & Africa Durvalumab Sales by Application (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Durvalumab Sales by Application (2021-2026) & (K Pcs)
Table 70. Direct Channel Pros & Cons
Table 71. Indirect Channel Pros & Cons
Table 72. Durvalumab Typical Distributors
Table 73. Durvalumab Typical Customers
List of Figures
Figure 1. Durvalumab Picture
Figure 2. Global Durvalumab Sales Market Share by Type in 2020
Figure 3. 2.4mL Injection
Figure 4. 10mL Injection
Figure 5. Global Durvalumab Sales Market Share by Application in 2020
Figure 6. Locally Advanced Urothelial Carcinoma
Figure 7. Metastatic Urothelial Carcinoma
Figure 8. Other
Figure 9. Global Durvalumab Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 10. Global Durvalumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Durvalumab Sales (2016-2026) & (K Pcs)
Figure 12. Global Durvalumab Price by Type (2016-2026) & (USD/Pcs)
Figure 13. Global Durvalumab Production Capacity (2016-2026) & (K Pcs)
Figure 14. Global Durvalumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Durvalumab Market Drivers
Figure 16. Durvalumab Market Restraints
Figure 17. Durvalumab Market Trends
Figure 18. Global Durvalumab Sales Market Share by Manufacturer in 2020
Figure 19. Global Durvalumab Revenue Market Share by Manufacturer in 2020
Figure 20. Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Durvalumab Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Durvalumab Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Durvalumab Sales Market Share by Region (2016-2026)
Figure 24. Global Durvalumab Revenue Market Share by Region (2016-2026)
Figure 25. North America Durvalumab Revenue (2016-2026) & (USD Million)
Figure 26. Europe Durvalumab Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Durvalumab Revenue (2016-2026) & (USD Million)
Figure 28. South America Durvalumab Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Durvalumab Revenue (2016-2026) & (USD Million)
Figure 30. Global Durvalumab Sales Market Share by Type (2016-2026)
Figure 31. Global Durvalumab Revenue Market Share by Type (2016-2026)
Figure 32. Global Durvalumab Price by Type (2016-2026) & (USD/Pcs)
Figure 33. Global Durvalumab Sales Market Share by Application (2016-2026)
Figure 34. Global Durvalumab Revenue Market Share by Application (2016-2026)
Figure 35. Global Durvalumab Price by Application (2016-2026) & (USD/Pcs)
Figure 36. North America Durvalumab Sales Market Share by Type (2016-2026)
Figure 37. North America Durvalumab Sales Market Share by Application (2016-2026)
Figure 38. North America Durvalumab Sales Market Share by Country (2016-2026)
Figure 39. North America Durvalumab Revenue Market Share by Country (2016-2026)
Figure 40. United States Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Durvalumab Sales Market Share by Type (2016-2026)
Figure 44. Europe Durvalumab Sales Market Share by Application (2016-2026)
Figure 45. Europe Durvalumab Sales Market Share by Country (2016-2026)
Figure 46. Europe Durvalumab Revenue Market Share by Country (2016-2026)
Figure 47. Germany Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Durvalumab Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Durvalumab Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Durvalumab Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Durvalumab Revenue Market Share by Region (2016-2026)
Figure 56. China Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Durvalumab Sales Market Share by Type (2016-2026)
Figure 63. South America Durvalumab Sales Market Share by Application (2016-2026)
Figure 64. South America Durvalumab Sales Market Share by Country (2016-2026)
Figure 65. South America Durvalumab Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Durvalumab Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Durvalumab Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Durvalumab Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Durvalumab Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Durvalumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
24/7 Research Support
Phone: +1 424 253 0807 
